{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:15:53Z","timestamp":1793229353551,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301609"],"award-info":[{"award-number":["82301609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021ZD0201807"],"award-info":[{"award-number":["2021ZD0201807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406900"],"award-info":[{"award-number":["2022YFC2406900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110880","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:28:10Z","timestamp":1771054090000},"page":"110880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diminazene attenuates astrocytic oxidative stress and neuronal ferroptosis via miR-10b-3p\/NOX4 axis in Alzheimer's Disease Model"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0087-7297","authenticated-orcid":false,"given":"Zhaohan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110880_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110880_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021059","article-title":"Alzheimer's disease-biochemical and psychological background for diagnosis and treatment","volume":"24","author":"Beata","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/HYPERTENSIONAHA.115.05185","article-title":"Activation of the neuroprotective angiotensin-converting enzyme 2 in rat ischemic stroke","volume":"66","author":"Bennion","year":"2015","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110880_bib5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4103\/1673-5374.390973","article-title":"NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases","volume":"19","author":"Boonpraman","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110880_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.14336\/AD.2015.0825","article-title":"The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease","volume":"6","author":"Budni","year":"2015","journal-title":"Aging Disease"},{"key":"10.1016\/j.neuropharm.2026.110880_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108373","article-title":"Molecular mechanisms of ferroptosis and their involvement in brain diseases","volume":"244","author":"Costa","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110880_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41419-022-05454-9","article-title":"Astrocyte-derived exosomal nicotinamide phosphoribosyltransferase (Nampt) ameliorates ischemic stroke injury by targeting AMPK\/mTOR signaling to induce autophagy","volume":"13","author":"Deng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110880_bib9","first-page":"1537","article-title":"Microglia and astrocytes in Alzheimer's disease: significance and summary of recent advances","volume":"15","author":"Deng","year":"2024","journal-title":"Aging Disease"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110880_bib10","first-page":"4175","article-title":"Identification and functional analysis of microRNAs in rats following focal cerebral ischemia injury","volume":"19","author":"Duan","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2026.110880_bib11","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.2147\/JIR.S343575","article-title":"Angiotensin-(1-7) analogue AVE0991 modulates astrocyte-mediated neuroinflammation via lncRNA SNHG14\/miR-223-3p\/NLRP3 pathway and offers neuroprotection in a transgenic mouse model of Alzheimer's disease","volume":"14","author":"Duan","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110880_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110880_bib13","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.7150\/thno.81951","article-title":"High-intensity interval training ameliorates Alzheimer's disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization","volume":"13","author":"Feng","year":"2023","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110880_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4103\/1673-5374.389362","article-title":"Ferroptosis mechanism and Alzheimer's disease","volume":"19","author":"Feng","year":"2024","journal-title":"Neural Regen. Res."},{"issue":"7-9","key":"10.1016\/j.neuropharm.2026.110880_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/ars.2023.0002","article-title":"NADPH oxidases in neurodegenerative disorders: mechanisms and therapeutic opportunities","volume":"41","author":"Fiadeiro","year":"2024","journal-title":"Antioxidants Redox Signal."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110880_bib16","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1007\/s12035-017-0630-3","article-title":"Endogenous expression of ODN-related peptides in astrocytes contributes to cell protection against oxidative stress: astrocyte-neuron crosstalk relevance for neuronal survival","volume":"55","author":"Ghouili","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110880_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","article-title":"Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration","volume":"12","author":"Hambright","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","article-title":"miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement","volume":"8","author":"Hoss","year":"2015","journal-title":"BMC Med. Genom."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110880_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70299","article-title":"Astrocyte in neurological disease: pathogenesis and therapy","volume":"6","author":"Huang","year":"2025","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110880_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jnc.15519","article-title":"Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease","volume":"159","author":"Jakaria","year":"2021","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110880_bib22","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110880_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1570159X11311020007","article-title":"ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke","volume":"11","author":"Jiang","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.110880_bib24","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1111\/bph.12770","article-title":"Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas\/eNOS-dependent pathway","volume":"171","author":"Jiang","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-020-01932-z","article-title":"Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury","volume":"17","author":"Jiao","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110880_bib26","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1007\/s12035-018-0966-3","article-title":"Stimulation of ACE2\/ANG(1-7)\/Mas axis by diminazene ameliorates Alzheimer's disease in the D-Galactose-Ovariectomized rat model: role of PI3K\/Akt pathway","volume":"55","author":"Kamel","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-022-00296-z","article-title":"Advances in the development of new biomarkers for Alzheimer's disease","volume":"11","author":"Klyucherev","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110880_bib28","first-page":"1900","article-title":"New approaches targeting the renin-angiotensin system: inhibition of brain aminopeptidase A, ACE2 ubiquitination, and angiotensinogen","volume":"39","author":"Lazartigues","year":"2023","journal-title":"Can. J. Cardiol."},{"issue":"721","key":"10.1016\/j.neuropharm.2026.110880_bib29","doi-asserted-by":"crossref","first-page":"eadi7828","DOI":"10.1126\/scitranslmed.adi7828","article-title":"Neuroinflammation: an astrocyte perspective","volume":"15","author":"Lee","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2026.110880_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.653881","article-title":"NF-\u03baB-Induced upregulation of miR-146a-5p promoted hippocampal neuronal oxidative stress and pyroptosis via TIGAR in a model of Alzheimer's disease","volume":"15","author":"Lei","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110880_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/DDDT.S252351","article-title":"ACE2 attenuates epithelial-mesenchymal transition in MLE-12 cells induced by silica","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"5-6","key":"10.1016\/j.neuropharm.2026.110880_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/neu.2021.0382","article-title":"Restoration of brain angiotensin-converting enzyme 2 alleviates neurological deficits after severe traumatic brain injury via mitigation of pyroptosis and apoptosis","volume":"39","author":"Li","year":"2022","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2006.04.014","article-title":"Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors","volume":"201","author":"Lin","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117679","article-title":"SuanZaoRen decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1\/Nrf2 signaling pathway","volume":"323","author":"Long","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.844534","article-title":"A neuron, microglia, and astrocyte triple Co-culture model to study Alzheimer's disease","volume":"14","author":"Luchena","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13578-024-01266-w","article-title":"NOX4-mediated astrocyte ferroptosis in Alzheimer's disease","volume":"14","author":"Maimaiti","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.neuropharm.2026.110880_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102575","article-title":"How neurons die in Alzheimer's disease: implications for neuroinflammation","volume":"75","author":"Mangalmurti","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110880_bib38","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13041-023-01040-y","article-title":"Activation of angiotensin-converting enzyme 2 produces an antidepressant-like effect via MAS receptors in mice","volume":"16","author":"Nakagawasai","year":"2023","journal-title":"Mol. Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13202","article-title":"Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment","volume":"34","author":"Nie","year":"2024","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111198","article-title":"Captopril prevents depressive-like behavior in an animal model of depression by enhancing hippocampal neurogenesis via activation of the ACE2\/Ang (1-7)\/Mas receptor\/AMPK\/BDNF pathway","volume":"136","author":"Odaira-Satoh","year":"2025","journal-title":"Progress Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110880_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108671","article-title":"MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease","volume":"196","author":"Pan","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110880_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101947","article-title":"NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases","volume":"41","author":"Park","year":"2021","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110880_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11111487","article-title":"AngIV-Analog dihexa rescues cognitive impairment and recovers memory in the APP\/PS1 mouse via the PI3K\/AKT signaling pathway","volume":"11","author":"Sun","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110880_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00424-021-02645-9","article-title":"MiR-10b-3p alleviates cerebral ischemia\/reperfusion injury by targeting Kr\u00fcppel-like factor 5 (KLF5)","volume":"474","author":"Sun","year":"2022","journal-title":"Pflueg. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib46","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/JIR.S401385","article-title":"Diminazene ameliorates neuroinflammation by suppression of astrocytic miRNA-224-5p\/NLRP3 axis in Alzheimer's disease model","volume":"16","author":"Sun","year":"2023","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110880_bib47","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jalz.2019.06.4952","article-title":"Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid","volume":"15","author":"Takousis","year":"2019","journal-title":"Alzheimer's Dementia : J. Alzheimer's Assoc."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110880_bib48","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1007\/s12035-024-04023-9","article-title":"NRF2 deficiency promotes ferroptosis of astrocytes mediated by oxidative stress in Alzheimer's disease","volume":"61","author":"Tang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112654","article-title":"Effect of Diminazene aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension","volume":"139","author":"Tiwari","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110880_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110880_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12222","article-title":"Extracellular vesicles enclosed-miR-421 suppresses air pollution (PM(2.5))-induced cardiac dysfunction via ACE2 signalling","volume":"11","author":"Wang","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.neuropharm.2026.110880_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116597","article-title":"The combination of Alisma and Atractylodes ameliorates cerebral ischaemia\/reperfusion injury by negatively regulating astrocyte-derived exosomal miR-200a-3p\/141-3p by targeting SIRT1","volume":"313","author":"Wei","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110880_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-022-02548-1","article-title":"MicroRNA-22-3p ameliorates Alzheimer's disease by targeting SOX9 through the NF-\u03baB signaling pathway in the hippocampus","volume":"19","author":"Xia","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110880_bib55","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1002\/alz.14254","article-title":"Temporal trend and attributable risk factors of Alzheimer's disease and other dementias burden in China: findings from the global burden of disease study 2021","volume":"20","author":"Yang","year":"2024","journal-title":"Alzheimer's Dementia : J. Alzheimer's Assoc."},{"key":"10.1016\/j.neuropharm.2026.110880_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102838","article-title":"The evolution of Alzheimer's disease: from mitochondria to microglia","author":"Yang","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110880_bib57","first-page":"6997","article-title":"Effects and mechanism of amyloid \u03b21-42 on mitochondria in astrocytes","volume":"17","author":"Yao","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110880_bib58","doi-asserted-by":"crossref","DOI":"10.1530\/REP-24-0242","article-title":"Diminazene aceturate, an ACE2 activator, ameliorates testicular injury in diet-induced obese mice","volume":"169","author":"Yue","year":"2025","journal-title":"Reproduction (Cambridge, England)"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110880_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer's disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prevent. Alzheimer's Dis."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.110880_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147789","article-title":"The potential role of miRNA-Regulated autophagy in Alzheimer's disease","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.110880_bib61","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomedicine Pharmacotherapy = Biomed. Pharmacotherapie"},{"key":"10.1016\/j.neuropharm.2026.110880_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039241","article-title":"ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T07:57:12Z","timestamp":1779004632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"alternative-id":["S0028390826000535"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110880","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diminazene attenuates astrocytic oxidative stress and neuronal ferroptosis via miR-10b-3p\/NOX4 axis in Alzheimer's Disease Model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110880"}}